POSTTREATMENT POLYP REGRESSION AND RISK OF MASSIVE SUBMACULAR HEMORRHAGE IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology,General Medicine
Reference16 articles.
1. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy;Spaide;Retina,1995
2. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics;Sho;Arch Ophthalmol,2003
3. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy;Koh;Retina,2012
4. Polypoidal choroidal vasculopathy: clinical features and genetic predisposition;Honda;Ophthalmologica,2014
5. Pigment epithelial detachment in polypoidal choroidal vasculopathy;Tsujikawa;Am J Ophthalmol,2007
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and validation of optical coherence tomography (OCT) and OCT angiography prediction model for short-term vitreous haemorrhage secondary to polypoidal choroidal vasculopathy;British Journal of Ophthalmology;2024-08-24
2. Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept;Scientific Reports;2024-01-21
3. Seven-year outcomes of combined treatment of anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy; according to polypoidal lesion regression;BMC Ophthalmology;2023-12-14
4. Twenty‐four‐month real‐life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians;Clinical & Experimental Ophthalmology;2023-10-23
5. Seven-year Outcomes of Combined Treatment of Anti-Vascular Endothelial Growth Factor with Photodynamic Therapy for Polypoidal Choroidal Vasculopathy; According to Polypoidal Lesion Regression;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3